3,4,5-Tri-
O-acetyl-2-[
18F]fluoro-2-deoxy-
D-
glucopyranosyl 1-phenylthiosulfonate (Ac
3-[
18F]FGlc-PTS) was developed as a thiol-reactive labelin
g rea
gent for the site-specific
18F-
glycosylation of peptides. Takin
g advanta
geof hi
ghly accessible 1,3,4,6-tetra-
O-acetyl-2-deoxy-2-[
18F]fluoro
glucopyranose, a three-step radiochemical pathwaywas investi
gated and optimized, providin
g Ac
3-[
18F]FGlc-PTS in a radiochemical yield of about 33% in 90 min(decay-corrected and based on startin
g [
18F]fluoride). Ac
3-[
18F]FGlc-PTS was reacted with the model pentapeptideCAKAY, confirmin
g chemoselectivity and excellent conju
gation yields of &
gt;90% under mild reaction conditions.The optimized method was adopted to the
18F-
glycosylation of the
ges/
gifchars/alpha.
gif" BORDER=0>
vges/
gifchars/beta2.
gif" BORDER=0 ALIGN="middle">
3-affine peptide c(RGDfC), achievin
g hi
ghconju
gation yields (95%, decay-corrected). The
ges/
gifchars/alpha.
gif" BORDER=0>
vges/
gifchars/beta2.
gif" BORDER=0 ALIGN="middle">
3 bindin
g affinity of the
glycosylated c(RGDfC) remaineduninfluenced as determined by competition bindin
g studies versus
125I-echistatin usin
g both isolated
ges/
gifchars/alpha.
gif" BORDER=0>
vges/
gifchars/beta2.
gif" BORDER=0 ALIGN="middle">
3 andhuman umbilical vein endothelial cells (
Ki = 68 ± 10 nM (
ges/
gifchars/alpha.
gif" BORDER=0>
vges/
gifchars/beta2.
gif" BORDER=0 ALIGN="middle">
3) versus
Ki = 77 ± 4 nM (HUVEC)). The wholeradiosynthetic procedure, includin
g the preparation of the
18F-
glycosylatin
g rea
gent Ac
3-[
18F]FGlc-PTS, peptideli
gation, and final HPLC purification, provided a decay-uncorrected radiochemical yield of 13% after a totalsynthesis time of 130 min. Ac
3-[
18F]FGlc-PTS represents a novel
18F-labelin
g rea
gent for the mild chemoselective
18F-
glycosylation of peptides indicatin
g its potential for the desi
gn and development of
18F-labeled bioactiveS-
glycopeptides suitable to study their pharmacokinetics in vivo by positron emission tomo
graphy (PET).